Teva Fights Eli Lilly's Bid To Toss Migraine Drug IP Case
Teva Pharmaceuticals says that Eli Lilly shouldn't be able to dodge a suit alleging an Eli Lilly migraine drug infringes a pair of Teva patents, arguing that the complaint is adequately...To view the full article, register now.
Already a subscriber? Click here to view full article